JNJ vs TASK · P/E 17, rev $49.37B vs P/E 4.8, rev $995.0M
Johnson & Johnson (JNJ) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the JNJ and TASK stock pages for the full models.
Not investment advice.